Management and prediction of immune-related adverse events for PD1/PDL-1 immunotherapy in colorectal cancer

Programmed cell death protein (PD-1) is an important immunosuppressive molecule, which can inhibit interaction between PD-1 and its ligand PD-L1, further enhancing the T cell response and anti-tumor activity, which is called immune checkpoint blockade. Immunotherapy, represented by immune checkpoint...

Descripción completa

Detalles Bibliográficos

Autores principales:	Liting Sun, Cong Meng, Xiao Zhang, Jiale Gao, Pengyu Wei, Jie Zhang, Zhongtao Zhang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2023-04-01
Colección:	Frontiers in Pharmacology
Materias:	colorectal cancer immunotherapy PD-1/PD-L1 inhibitors immune-related adverse events prediction
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1167670/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!